An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
Wanbo Tai(Shenzhen Bay Laboratory), Gong Cheng(Shenzhen Bay Laboratory), Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Lü(Center for Drug Evaluation and Research), Shengyong Feng(Peking University), Liting Ren(Tsinghua University), Benjie Chai(Center for Life Sciences), Jinzhong Lin(Fudan University), Guangyu Zhao(Academy of Military Medical Sciences), Qiangming Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhuming Cai(Shenzhen Bay Laboratory), Shuaiyao Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mujia Pang(Shenzhen Bay Laboratory), Dong Chen(Mayo Clinic in Arizona), Wenhai Yu(Kunming Institute of Zoology), Penghua Wang(New York Medical College), Huicheng Shi(Peking University), Xu Tan(490 BioTech (United States))
Cited by 59